查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1929595

疝气和腹壁手术产品市场（按产品类型、解剖结构、手术方式、材料类型、最终用途和分销渠道划分），全球预测，2026-2032年

Hernia & Abdominal Wall Surgery Products Market by Product Type, Anatomical Location, Procedure Type, Material Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年疝气和腹壁手术产品市场价值为8.1421亿美元，预计到2026年将成长至8.7526亿美元，年复合成长率为6.50%，到2032年将达到12.6593亿美元。

关键市场统计数据
基准年 2025 8.1421亿美元
预计年份：2026年 8.7526亿美元
预测年份 2032 1,265,930,000 美元
复合年增长率 (%) 6.50%

本书以临床观点，介绍了不断发展的医疗设备趋势、手术偏好以及影响疝气和腹壁治疗的证据需求。

疝气和腹壁手术始终处于临床紧迫性和持续创新之间的交会点，其驱动力在于既要改善患者预后，又要优化手术全期效率。这些手术中使用的器械和耗材涵盖了广泛的技术频谱，从植入式网片和生物移植物到先进的固定係统和微创器械。生物材料和手术平台的进步，以及外科医师偏好的转变，造就了因临床适应症和医疗机构而异的多样化应用模式。

本文简要分析了正在重塑临床实践、器械研发和采购重点的技术、监管和供应链变革。

现代腹壁外科手术格局正受到多种因素的共同影响，这些因素正在重塑临床实践和商业策略。微创平台的技术进步，特别是机器人辅助系统的成熟，正在拓展外科医生进行复杂修復和精准分离的能力，从而影响对相容网片、固定方法和器械的需求。同时，材料科学的进步也拓展了选择范围，从传统的合成材料转向复合和生物网膜网片旨在解决污染风险、生物反应和长期重塑等问题。

评估2025年美国对医疗设备采购、价格透明度和临床准入征收关税对营运、采购和供应连续性的影响

2025年美国实施的政策和贸易变化为腹壁外科领域的跨国供应链和临床采购惯例带来了新的考量。关税调整及相关贸易措施改变了零件和成品的采购策略，尤其对于那些依赖跨境製造网路生产聚合物、生物製程和精密仪器的公司而言更是如此。为此，製造商和经销商正在评估替代筹资策略、区域製造地地点和库存管理技术，以维持供应的连续性并控製成本风险。

详细的細項分析，将采用趋势与产品类型、解剖适应症、手术路径、材料选择、最终用户和分销管道联繫起来。

这种细分为理解疝气和腹壁手术生态系统中产品开发、临床应用和分销策略如何相互交织提供了一个实用的框架。以产品类型为基础的市场结构包括：防沾黏产品（分为薄膜、凝胶和粉末製剂）；固定装置（包括黏合剂、缝线和缝合钉）。网片产品系列分为生物网片、复合网片和合成网片。生物网片进一步细分为同种异体移植、自体移植和异质骨移植；复合网片分为重型和轻型；合成网片则依聚合物种类细分，包括聚酯、聚丙烯和聚四氟乙烯（PTFE）。手术器械包括牵开器、手术刀和套管针系统。这些产品特性影响临床选择标准，涵盖了从操作特性和组织相容性到微创手术中的易用性等各个方面。

从跨区域观点探讨采纳、监管差异、报销影响和供应韧性如何影响全球主要医疗保健区域的临床可近性

区域趋势对腹壁外科产品的研发重点、监管策略和上市时间表有显着影响。在美洲，领先的公立和私立医疗机构正积极推动微创和机器人技术的早期应用，而大规模综合医疗系统则强调标准化通讯协定、医疗设备整合和疗效评估，以加速临床疗效显着的产品上市。相较之下，欧洲、中东和非洲（EMEA）的法规结构和报销机制更为多样化，区域核准流程、国家采购流程以及医院间的合作能力共同决定了技术应用的速度和范围。一些地区优先考虑长期安全性数据和成本效益评估，这会影响生物製药和合成製剂的商业性化推广路径。

策略性公司分析和竞争考察揭示了产品系列的广度、临床证据和供应可靠性如何使腹壁手术生态系统中的公司脱颖而出。

疝气和腹壁手术领域的竞争格局呈现出两极化的特点：既有成熟的外科器械製造商，也有专注于生物製药、固定係统和数位化手术整合等细分领域的灵活创新型专业公司。领导企业凭藉其全面的产品组合脱颖而出，这些产品组合将经临床检验的植入与器械和教育服务相结合，从而降低手术操作的差异性。其策略性倡议通常着重于收购互补技术、与临床研究网络合作以产生长期证据，以及投资于能够增强手术全期支持和结果追踪的数位化平台。

为製造商、医疗保健提供者、经销商和支付方提供实际有效的建议，以加速安全应用、增强供应链韧性并优化价值。

价值链上的各相关人员可以采取实际行动，在确保临床疗效和营运稳定性的同时，加速创新技术的应用。製造商应优先产生反映真实世界实践的有意义的临床证据，投资于外科医生教育和指导计画以缩短学习曲线，并设计能够适应不同手术方法和设施限制的产品。此外，他们还应透过对多家供应商进行资格认证、在条件允许的地区投资生产以及建立健全的品质和监管流程来提高供应链透明度，从而支持地域扩张。

该报告对支持其结论的混合定性和定量调查方法、相关人员参与和检验通讯协定进行了透明的描述。

本报告的分析采用了混合研究方法，结合了质性初步研究和定量检验工作。主要研究内容包括与各专科的执业外科医生、医院和门诊手术中心的采购人员、医疗设备设计和监管专家以及製造和分销机构的高级管理人员进行结构化访谈和咨询会议。这些对话揭示了不同医疗机构在营运方面面临的挑战、临床优先事项以及实施障碍。

简洁的结论整合了策略要务、临床重点和营运行动，旨在协调相关人员，推动疝气和腹壁护理。

研究结果概述凸显了一个充满活力且机会丰富的领域，在这个领域中，材料创新、不断发展的外科技术和商业策略相互交融，共同塑造着临床实践。关键建议强调了以下几点的重要性：产品设计应与实际手术流程相契合；投资于能够证明长期疗效的临床证据的生成；以及构建供应链韧性，以抵御地缘政治和贸易相关的干扰。同样重要的是，外科医生、采购团队和製造商之间需要进行多学科合作，以规范通讯协定，确保患者在不同临床环境中获得一致的就医体验。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按产品类型分類的疝气和腹壁手术产品市场

  • 抗黏附剂
    • 电影
    • 凝胶
    • 粉末
  • 固定装置
    • 黏合剂
    • 缝合线
    • 钉
  • 网
    • 生物网膜
    • 复合网格
    • 合成网
  • 手术器械
    • 牵开器
    • 女性
    • 套管针系统

9. 按解剖部位分類的疝气和腹壁手术产品市场

  • 大腿
    • 双边
    • 单方面
  • 食道裂孔疝
    • 食道旁疝
    • 滑翔型
  • 切口疝
    • 腹腔镜
    • 开放性手术
  • 鼠蹊部
    • 直疝
    • 间接疝
    • 裤型疝
  • 脐疝气
    • 合成的
    • 简单的

10. 依手术方法分類的疝气和腹壁手术产品市场

  • 腹腔镜修补术
    • TAPP
    • TEP
  • 开放式维修
  • 机器人辅助维修
    • 多埠
    • 单站点

11. 按材料类型分類的疝气和腹壁手术产品市场

  • 生物材料
    • 同种异体移植
    • 自体移植
    • 异质骨移植
  • 合成材料
    • 聚酯纤维
    • 聚丙烯
    • PTFE

12. 依最终用户分類的疝气和腹壁手术产品市场

  • 门诊手术中心
  • 诊所
  • 医院

13. 疝气和腹壁手术产品市场（依分销管道划分）

  • 直销
  • 批发商
  • 在线的

14. 各地区疝气及腹壁手术产品市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

15. 按组别分類的疝气和腹壁手术产品市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各国疝气及腹壁手术产品市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国疝气和腹壁手术产品市场

第十八章：中国疝气与腹壁手术产品市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Atrium Medical Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Braun Surgical
  • Coloplast A/S
  • Conmed Corporation
  • Cook Medical LLC
  • Ethicon, Inc.
  • Integra LifeSciences Corporation
  • Leon Berard SAS
  • Medline Industries, LP
  • Medtronic plc
  • Molnlycke Health Care AB
  • Pfizer Inc.
  • Pfm Medical AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0A380695183E

The Hernia & Abdominal Wall Surgery Products Market was valued at USD 814.21 million in 2025 and is projected to grow to USD 875.26 million in 2026, with a CAGR of 6.50%, reaching USD 1,265.93 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 814.21 million
Estimated Year [2026] USD 875.26 million
Forecast Year [2032] USD 1,265.93 million
CAGR (%) 6.50%

An informed and clinically focused introduction to the evolving device landscape, procedural preferences, and evidence imperatives shaping hernia and abdominal wall care

Hernia and abdominal wall surgery remain at the intersection of clinical urgency and sustained innovation, driven by an imperative to improve patient outcomes while optimizing perioperative efficiency. Devices and consumables used in these procedures span a wide technical spectrum, from implantable meshes and biologic grafts to advanced fixation systems and minimally invasive instruments. Advances in biomaterials and procedural platforms have converged with evolving surgeon preferences, resulting in diverse adoption patterns that vary by clinical indication and healthcare setting.

Clinical pathways are increasingly guided by evidence that balances short-term recovery metrics with long-term functional outcomes. As a consequence, product developers are responding with solutions that emphasize ease of use in the operating room, predictable tissue integration, and lower complication profiles. Simultaneously, procurement leaders and hospital systems are prioritizing supply chain predictability and product standardization to reduce variability in patient care.

Moreover, digital tools and data-driven perioperative programs are reshaping how outcomes are tracked and how devices are evaluated in real-world settings. These dynamics create both opportunities and responsibilities for manufacturers, clinicians, and health systems as they align on value measures, training modalities, and post-market surveillance to ensure therapies deliver consistent clinical benefit across diverse patient populations.

A concise analysis of convergent technological, regulatory, and supply chain shifts that are reorienting clinical practice, device development, and procurement priorities

The contemporary landscape of abdominal wall surgery is being transformed by several convergent forces that are redefining clinical practice and commercial strategy. Technological progress in minimally invasive platforms-particularly the maturation of robotic-assisted systems-has expanded surgeon capabilities for complex repairs and refined dissection, thereby influencing demand for compatible meshes, fixation methods, and instrumentation. Concurrently, materials science advances have broadened options from traditional synthetic constructs to composite and biologic meshes designed to address contamination risk, host response, and long-term remodeling.

Beyond technology, regulatory pathways and clinical guidelines have evolved to place greater emphasis on patient safety and long-term outcomes, which in turn amplifies the importance of robust clinical evidence and post-market registries. Supply chain resilience and localization strategies have emerged as strategic priorities for manufacturers seeking to mitigate disruption and manage costs while maintaining quality and availability. Additionally, shifting reimbursement paradigms and hospital procurement models are encouraging bundled care approaches that integrate devices, perioperative protocols, and outcome monitoring.

Collectively, these shifts demand that stakeholders adopt a systems-level perspective: product development must align with surgical workflows and payer expectations; clinical education must support safe adoption; and manufacturers must invest in data generation and supply chain agility to stay competitive in a rapidly evolving environment.

Evaluating the operational, procurement, and supply continuity consequences of 2025 United States tariff measures on device sourcing, pricing transparency, and clinical access

Policy and trade changes enacted in the United States in 2025 have introduced a new set of considerations for multinational supply chains and clinical procurement practices in abdominal wall surgery. Tariff adjustments and related trade measures have altered the calculus for sourcing components and finished devices, particularly for firms that rely on cross-border manufacturing networks for polymers, biologic processing, and precision instruments. In response, manufacturers and distributors have been evaluating alternative sourcing strategies, regional manufacturing footprints, and inventory approaches to preserve continuity of supply and control cost exposure.

Clinicians and hospital procurement teams are encountering increased complexity in vendor negotiations and total cost assessments, prompting a renewed emphasis on predictable lead times and transparent costing. The response from suppliers has included efforts to enhance local inventory buffers, accelerate qualification of secondary suppliers, and re-examine pricing models to share risk across the value chain. For devices that incorporate specialized materials or proprietary biologic inputs, regulatory and quality validation timelines have become a critical component of any relocation or supplier diversification strategy.

While these measures add transactional complexity, they also create openings for manufacturers that can demonstrate supply chain reliability, proven clinical effectiveness, and streamlined regulatory compliance. Consequently, strategic investments in regional manufacturing capability, enhanced quality systems, and direct engagement with procurement stakeholders are proving to be valuable differentiators in an environment shaped by evolving trade policy.

In-depth segmentation analysis that connects product modalities, anatomical indications, procedural pathways, material choices, end users, and distribution channels to adoption dynamics

Segmentation provides a practical framework for understanding how product development, clinical adoption, and distribution strategies intersect across the hernia and abdominal wall surgery ecosystem. Based on product type, the landscape includes Adhesion Barrier products differentiated as film, gel, and powder formulations; Fixation Devices encompassing adhesives, sutures, and tacks; Mesh offerings segmented into Biologic Mesh, Composite Mesh, and Synthetic Mesh with further distinctions such as Allograft, Autograft, and Xenograft for biologics, Heavyweight and Lightweight variants for composite constructions, and polymer-specific choices like polyester, polypropylene, and PTFE for synthetics; and Surgical Instruments including retractors, scalpels, and trocar systems. These product distinctions shape clinical selection criteria, from handling characteristics and tissue compatibility to ease of deployment in minimally invasive settings.

Anatomical location segmentation highlights clinical heterogeneity with categories including femoral repairs (both bilateral and unilateral), hiatal variants (paraesophageal and sliding), incisional procedures (laparoscopic and open), inguinal types (direct, indirect, and pantaloon), and umbilical repairs classified as complex or simple. Procedure type segmentation further refines adoption dynamics, distinguishing laparoscopic repairs and their TAPP and TEP subapproaches, open repairs, and the growing cohort of robotic repairs that include multiport and single-site configurations. Material type delineation bifurcates offerings into biologic and synthetic routes, each with attendant subtypes and clinical trade-offs, while end-user segmentation captures the distinct procurement, workflow, and training needs of ambulatory surgical centers, clinics, and hospitals. Distribution channel segmentation contrasts direct sales, distributor relationships, and online channels that each influence pricing, service levels, and post-sale support.

Taken together, these segmentation lenses reveal that clinical choice is rarely driven by a single attribute. Instead, a combination of device characteristics, surgical approach, institutional capabilities, and supply chain considerations determines product adoption and long-term utilization patterns. Manufacturers that align product innovation with the nuanced requirements of specific anatomical indications, procedural approaches, and end-user settings will be better positioned to support clinical teams and capture durable adoption.

Cross-regional perspectives on adoption, regulatory variance, reimbursement influence, and supply resilience shaping clinical availability in major global healthcare regions

Regional dynamics exert a powerful influence on product development priorities, regulatory strategy, and adoption timelines in abdominal wall surgery. In the Americas, advanced private and public institutions often drive early adoption of minimally invasive and robotic techniques, while large integrated health systems emphasize standardized protocols, device consolidation, and outcome measurement that can accelerate adoption of products with strong clinical evidence. In contrast, regulatory frameworks and reimbursement mechanisms across Europe, Middle East & Africa present a more heterogeneous landscape where local approvals, national procurement processes, and varying hospital capabilities shape the pace and scope of uptake. Some jurisdictions prioritize long-term safety data and cost-effectiveness assessments, which influences the commercial pathway for biologic versus synthetic options.

Asia-Pacific exhibits a mix of rapid technology adoption in urban tertiary centers and pragmatic device selection in resource-constrained settings, encouraging manufacturers to offer a range of product tiers and service models. Across all regions, workforce training and surgeon experience remain central determinants of new technology integration, and investment in education and proctoring programs is often required to translate technical potential into routine practice. Finally, regional supply chain realities and trade policy influence stocking decisions and contract structures, prompting stakeholders to balance global product consistency with locally tailored logistical strategies that support uninterrupted clinical service delivery.

Strategic corporate and competitive insights revealing how portfolio breadth, clinical evidence, and supply reliability differentiate firms in the abdominal wall surgery ecosystem

Competitive landscapes in the hernia and abdominal wall sphere are characterized by a blend of established surgical device firms and agile specialty companies that focus on discrete segments such as biologics, fixation systems, or digital surgery integrations. Leaders differentiate through comprehensive portfolios that combine clinically validated implants with instrumentation and educational services that reduce procedural variability. Strategic activity often centers on acquiring complementary technologies, partnering with clinical research networks to generate long-term evidence, and investing in digital platforms that extend perioperative support and outcomes tracking.

Smaller, nimble players frequently compete by offering novel materials, single-purpose instruments, or targeted service models that appeal to specific end users or clinical subpopulations. These firms can leverage focused clinical trials, investigator-led registries, and targeted training initiatives to build credibility and drive regional adoption. At the same time, larger corporations pursue scale advantages in manufacturing, distribution reach, and reimbursement navigation, which can create barriers to entry but also foster collaborative opportunities through licensing or co-development agreements.

Across the competitive set, meaningful differentiation increasingly hinges on the ability to demonstrate clinical benefit, ensure supply chain reliability, and provide comprehensive training and post-market surveillance. Companies that invest in these capabilities position themselves to capture both clinical trust and procurement preference in an environment where institutions prioritize predictable outcomes and operational continuity.

Practical and high-impact recommendations for manufacturers, providers, distributors, and payers to accelerate safe adoption, strengthen supply resilience, and optimize value

Stakeholders across the value chain can adopt tangible actions to accelerate innovation adoption while safeguarding clinical outcomes and operational stability. Manufacturers should prioritize the generation of meaningful clinical evidence that reflects real-world practice, invest in surgeon education and proctoring programs to shorten learning curves, and design products that accommodate diverse surgical approaches and facility constraints. In addition, manufacturers must strengthen supply chain transparency by qualifying multiple suppliers, investing in regional manufacturing where feasible, and establishing robust quality and regulatory pathways to support geographic expansion.

Hospitals and ambulatory centers should incorporate standardized implant selection protocols, outcome tracking, and multidisciplinary decision-making frameworks to ensure consistent patient care and to inform procurement choices. Procurement leaders can leverage long-term service agreements and collaborative contracting to balance cost control with supply continuity, while also encouraging vendors to provide training and data support. Distributors and channel partners should evolve toward value-added service models that include inventory management, clinician training, and data integration services to remain relevant in a landscape that increasingly values bundled delivery of products and services.

Finally, policymakers and payers can support appropriate adoption by aligning reimbursement structures with evidence-based care pathways and by facilitating post-market data collection to monitor long-term safety and effectiveness. By coordinating across stakeholders and emphasizing transparent evidence and supply practices, the ecosystem can improve patient outcomes while fostering sustainable innovation.

Transparent description of the mixed qualitative and quantitative research approach, stakeholder engagements, and validation protocols that support the report's conclusions

The analysis underpinning this report was developed using a mixed-methods research approach that combined primary qualitative engagement with quantitative validation exercises. Primary inputs included structured interviews and advisory sessions with practicing surgeons across specialties, procurement leaders in hospitals and ambulatory surgical centers, device design and regulatory experts, and senior executives from manufacturing and distribution organizations. These interactions were used to surface operational challenges, clinical priorities, and adoption barriers in diverse care settings.

Secondary research supported contextual understanding and included a review of peer-reviewed clinical literature, regulatory filings, device labeling, clinical registry outputs, and supplier disclosures. Data synthesis employed thematic analysis to identify recurrent patterns and triangulation techniques to corroborate insights across multiple sources. Where relevant, scenario-based assessments were used to explore supply chain resilience, adoption pathways, and the implications of policy changes.

Validation steps included expert peer review by clinical and commercial advisors as well as iterative feedback cycles with industry stakeholders to ensure findings were practical, actionable, and reflective of current clinical practice. This layered methodology balances depth of qualitative understanding with rigorous cross-checking to produce robust, decision-ready conclusions.

A succinct conclusion synthesizing strategic imperatives, clinical priorities, and operational actions stakeholders must align on to advance hernia and abdominal wall care

The collective evidence points to a dynamic and opportunity-rich field in which material innovation, procedural evolution, and commercial strategy intersect to shape clinical practice. Key takeaways emphasize the importance of aligning product design with real-world surgical workflows, investing in clinical evidence generation that speaks to long-term outcomes, and building supply chain resilience to withstand geopolitical and trade-related disruptions. Equally important is the role of multidisciplinary collaboration among surgeons, procurement teams, and manufacturers to standardize protocols and to ensure consistent patient experiences across care settings.

Looking ahead, stakeholders that combine technical excellence with operational reliability and transparent outcomes measurement will be positioned to influence adoption curves and to demonstrate sustained clinical value. Incremental improvements in device handling, fixation reliability, and biologic integration-paired with effective clinician training and data-driven outcome monitoring-can collectively reduce variability in results and enhance patient recovery. In an environment where payer and institutional decision-making increasingly rewards demonstrable value, coordinated strategies that integrate clinical, commercial, and logistical considerations are essential for long-term success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hernia & Abdominal Wall Surgery Products Market, by Product Type

  • 8.1. Adhesion Barrier
    • 8.1.1. Film
    • 8.1.2. Gel
    • 8.1.3. Powder
  • 8.2. Fixation Device
    • 8.2.1. Adhesives
    • 8.2.2. Sutures
    • 8.2.3. Tacks
  • 8.3. Mesh
    • 8.3.1. Biologic Mesh
    • 8.3.2. Composite Mesh
    • 8.3.3. Synthetic Mesh
  • 8.4. Surgical Instruments
    • 8.4.1. Retractors
    • 8.4.2. Scalpels
    • 8.4.3. Trocar System

9. Hernia & Abdominal Wall Surgery Products Market, by Anatomical Location

  • 9.1. Femoral
    • 9.1.1. Bilateral
    • 9.1.2. Unilateral
  • 9.2. Hiatal
    • 9.2.1. Paraesophageal
    • 9.2.2. Sliding
  • 9.3. Incisional
    • 9.3.1. Laparoscopic
    • 9.3.2. Open
  • 9.4. Inguinal
    • 9.4.1. Direct Hernia
    • 9.4.2. Indirect Hernia
    • 9.4.3. Pantaloon Hernia
  • 9.5. Umbilical
    • 9.5.1. Complex
    • 9.5.2. Simple

10. Hernia & Abdominal Wall Surgery Products Market, by Procedure Type

  • 10.1. Laparoscopic Repair
    • 10.1.1. TAPP
    • 10.1.2. TEP
  • 10.2. Open Repair
  • 10.3. Robotic Repair
    • 10.3.1. Multiport
    • 10.3.2. Single-Site

11. Hernia & Abdominal Wall Surgery Products Market, by Material Type

  • 11.1. Biologic
    • 11.1.1. Allograft
    • 11.1.2. Autograft
    • 11.1.3. Xenograft
  • 11.2. Synthetic
    • 11.2.1. Polyester
    • 11.2.2. Polypropylene
    • 11.2.3. PTFE

12. Hernia & Abdominal Wall Surgery Products Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Hernia & Abdominal Wall Surgery Products Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online

14. Hernia & Abdominal Wall Surgery Products Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Hernia & Abdominal Wall Surgery Products Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Hernia & Abdominal Wall Surgery Products Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Hernia & Abdominal Wall Surgery Products Market

18. China Hernia & Abdominal Wall Surgery Products Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Atrium Medical Corporation
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Boston Scientific Corporation
  • 19.9. Braun Surgical
  • 19.10. Coloplast A/S
  • 19.11. Conmed Corporation
  • 19.12. Cook Medical LLC
  • 19.13. Ethicon, Inc.
  • 19.14. Integra LifeSciences Corporation
  • 19.15. Leon Berard SAS
  • 19.16. Medline Industries, L.P.
  • 19.17. Medtronic plc
  • 19.18. Molnlycke Health Care AB
  • 19.19. Pfizer Inc.
  • 19.20. Pfm Medical AG
  • 19.21. Smith & Nephew plc
  • 19.22. Stryker Corporation
  • 19.23. Teleflex Incorporated
  • 19.24. W. L. Gore & Associates, Inc.
  • 19.25. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FILM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FILM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FILM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPOSITE MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPOSITE MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPOSITE MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC MESH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC MESH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC MESH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SCALPELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SCALPELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SCALPELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TROCAR SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TROCAR SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TROCAR SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PARAESOPHAGEAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PARAESOPHAGEAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PARAESOPHAGEAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SLIDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SLIDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SLIDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INDIRECT HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INDIRECT HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INDIRECT HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PANTALOON HERNIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PANTALOON HERNIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PANTALOON HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPLEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPLEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COMPLEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SIMPLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SIMPLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SIMPLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TAPP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TAPP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TAPP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TEP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TEP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY TEP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY OPEN REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MULTIPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MULTIPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MULTIPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SINGLE-SITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SINGLE-SITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SINGLE-SITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PTFE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PTFE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PTFE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ROBOTIC REPAIR, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY BIOLOGIC, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SYNTHETIC, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ADHESION BARRIER, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FIXATION DEVICE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY MESH, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY SURGICAL INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY ANATOMICAL LOCATION, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY FEMORAL, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY HIATAL, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INCISIONAL, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY INGUINAL, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE HERNIA & ABDOMINAL WALL SURGERY PRODUCTS MARKET SIZE, BY UMBILICAL, 2018-2032 (